See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: Dec. 20, 2004

Gastroesophageal Reflux Disease (GERD) Lung Cancer Macular Degeneration

(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:

Gastroesophageal Reflux Disease (GERD)

A research study to assess the safety and efficacy of an investigational medication for people with heartburn (also known as gastroesophageal reflux disease or GERD). Volunteers 18 to 65 who have at least a three-month history of heartburn may be eligible. Research site located in Tucson, Ariz.

More Information

Please see http://www.centerwatch.com/patient/studies/cat70.html.

-----

Lung Cancer

A research study of a combination of medications for the treatment of non-small cell lung cancer. Volunteers who have been diagnosed with non-squamous cell non-small cell lung cancer (stage IIIB disease with pleural effusion OR stage IV disease) whose cancer is recurrent or refractory may be eligible. Research sites located throughout the United States.

More Information

Please see http://www.centerwatch.com/patient/studies/cat34.html.

-----

Macular Degeneration

A research study to evaluate the safety and effectiveness of an investigational drug in patients, at least 50 years old, with a degenerative eye disease known as wet age-related macular degeneration (AMD). Research site located in Tampa, Fla.

More Information

Please see http://www.centerwatch.com/patient/studies/cat96.html.

-----

Copyright 2004 CenterWatch. All rights reserved.

Consumer News

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.